These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 20424769)
21. Peptide-substituted phthalocyanine photosensitizers: design, synthesis, photophysicochemical and photobiological studies. Göksel M; Durmuş M; Atilla D Photochem Photobiol Sci; 2016 Oct; 15(10):1318-1329. PubMed ID: 27714248 [TBL] [Abstract][Full Text] [Related]
22. A phthalocyanine-peptide conjugate with high in vitro photodynamic activity and enhanced in vivo tumor-retention property. Ke MR; Yeung SL; Fong WP; Ng DK; Lo PC Chemistry; 2012 Apr; 18(14):4225-33. PubMed ID: 22378352 [TBL] [Abstract][Full Text] [Related]
29. Smart Probe for Tracing Cancer Therapy: Selective Cancer Cell Detection, Image-Guided Ablation, and Prediction of Therapeutic Response In Situ. Yuan Y; Kwok RT; Tang BZ; Liu B Small; 2015 Sep; 11(36):4682-90. PubMed ID: 26113312 [TBL] [Abstract][Full Text] [Related]
30. Water-soluble aluminium phthalocyanine-polymer conjugates for PDT: photodynamic activities and pharmacokinetics in tumour-bearing mice. Brasseur N; Ouellet R; La Madeleine C; van Lier JE Br J Cancer; 1999 Jul; 80(10):1533-41. PubMed ID: 10408394 [TBL] [Abstract][Full Text] [Related]
31. [Fluorescence polarization used to derive cell membrane fluidity during photodynamic therapy]. Wei RH; Huang YP; Li SS; Qi CY Guang Pu Xue Yu Guang Pu Fen Xi; 2005 Nov; 25(11):1827-9. PubMed ID: 16499056 [TBL] [Abstract][Full Text] [Related]
32. Selective photosensitizer delivery into plasma membrane for effective photodynamic therapy. Kim J; Santos OA; Park JH J Control Release; 2014 Oct; 191():98-104. PubMed ID: 24892975 [TBL] [Abstract][Full Text] [Related]
33. A zinc(II) phthalocyanine conjugated with an oxaliplatin derivative for dual chemo- and photodynamic therapy. Lau JT; Lo PC; Fong WP; Ng DK J Med Chem; 2012 Jun; 55(11):5446-54. PubMed ID: 22646131 [TBL] [Abstract][Full Text] [Related]
34. Recent Advances in Activatable Organic Photosensitizers for Specific Photodynamic Therapy. Liu M; Li C Chempluschem; 2020 May; 85(5):948-957. PubMed ID: 32401421 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and in vitro photodynamic activities of di-alpha-substituted zinc(ii) phthalocyanine derivatives. Liu JY; Lo PC; Jiang XJ; Fong WP; Ng DK Dalton Trans; 2009 Jun; (21):4129-35. PubMed ID: 19452061 [TBL] [Abstract][Full Text] [Related]
36. A novel strategy for targeting photodynamic therapy. Molecular combo of photodynamic agent zinc(II) phthalocyanine and small molecule target-based anticancer drug erlotinib. Zhang FL; Huang Q; Zheng K; Li J; Liu JY; Xue JP Chem Commun (Camb); 2013 Oct; 49(83):9570-2. PubMed ID: 24018863 [TBL] [Abstract][Full Text] [Related]
37. A tumor-targeted activatable phthalocyanine-tetrapeptide-doxorubicin conjugate for synergistic chemo-photodynamic therapy. Ke MR; Chen SF; Peng XH; Zheng QF; Zheng BY; Yeh CK; Huang JD Eur J Med Chem; 2017 Feb; 127():200-209. PubMed ID: 28063352 [TBL] [Abstract][Full Text] [Related]
38. Dendrimer polymeric micelles for enhanced photodynamic cancer treatment. Park K J Control Release; 2009 Feb; 133(3):171. PubMed ID: 19103238 [No Abstract] [Full Text] [Related]
39. Positively charged phthalocyanine-arginine conjugates as efficient photosensitizer for photodynamic therapy. Wang A; Zhou R; Zhou L; Sun K; Jiang J; Wei S Bioorg Med Chem; 2017 Mar; 25(5):1643-1651. PubMed ID: 28153588 [TBL] [Abstract][Full Text] [Related]
40. Fully protected glycosylated zinc (II) phthalocyanine shows high uptake and photodynamic cytotoxicity in MCF-7 cancer cells. Kimani SG; Shmigol TA; Hammond S; Phillips JB; Bruce JI; MacRobert AJ; Malakhov MV; Golding JP Photochem Photobiol; 2013; 89(1):139-49. PubMed ID: 22803957 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]